support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

View:
format_list_bulleted grid_view

01/11/2021

CHEPLAPHARM acquires rights to Rivotril®
Archive
Read more chevron_right

01/05/2021

CHEPLAPHARM completes it´s largest acquisition so far
Investors Domain
Read more chevron_right

01/05/2021

CHEPLAPHARM completes it´s largest acquisition so far
Archive
Read more chevron_right

01/04/2021

CHEPLAPHARM acquires rights to Atacand® in more than 70 markets
Investors Domain
Read more chevron_right

01/04/2021

CHEPLAPHARM acquires rights to Atacand® in more than 70 markets
Archive
Read more chevron_right

12/21/2020

CHEPLAPHARM donates over €200,000 for Christmas
Press releases
Read more chevron_right

12/16/2020

CHEPLAPHARM proves its vigour
Investors Domain
Read more chevron_right

12/16/2020

CHEPLAPHARM proves its vigour
Press releases
Read more chevron_right

11/02/2020

CHEPLAPHARM closes another product portfolio acquisition
Press releases
Read more chevron_right

11/02/2020

CHEPLAPHARM closes another product portfolio acquisition
Archive Investor Relations Investors Domain
Read more chevron_right
Back to top expand_less